Matches in Wikidata for { <http://www.wikidata.org/entity/Q89468198> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q89468198 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q89468198 description "scientific article published on 29 January 2020" @default.
- Q89468198 description "wetenschappelijk artikel" @default.
- Q89468198 description "наукова стаття, опублікована 29 січня 2020" @default.
- Q89468198 name "Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study" @default.
- Q89468198 name "Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study" @default.
- Q89468198 type Item @default.
- Q89468198 label "Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study" @default.
- Q89468198 label "Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study" @default.
- Q89468198 prefLabel "Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study" @default.
- Q89468198 prefLabel "Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study" @default.
- Q89468198 P1433 Q89468198-813B86C8-DC27-4852-B414-45F5E882910D @default.
- Q89468198 P1476 Q89468198-94D78969-7D8D-4A53-9716-7CF7D2DC932D @default.
- Q89468198 P2093 Q89468198-0BD7D1AA-4494-40B2-8BAC-78651A712CE9 @default.
- Q89468198 P2093 Q89468198-C40DA615-5262-4D0D-8BB3-0791F10A165C @default.
- Q89468198 P2093 Q89468198-D3436C7F-8D76-4CC1-97FB-4F7E46959676 @default.
- Q89468198 P2093 Q89468198-DA9EF209-B6E1-4E35-B63C-B9304EF5C620 @default.
- Q89468198 P2093 Q89468198-FE04DF0E-5755-4CC1-9EA2-9AA02FCB80C9 @default.
- Q89468198 P31 Q89468198-D45617B1-A979-400F-AC43-539283920F7A @default.
- Q89468198 P356 Q89468198-A93013C4-2931-4D92-ACAD-CE03104715A2 @default.
- Q89468198 P50 Q89468198-4FF37717-8CE3-4CE8-8C45-98BD4DCD9F85 @default.
- Q89468198 P577 Q89468198-50ADE1B7-D9C7-4117-A5B3-2352F17888C1 @default.
- Q89468198 P698 Q89468198-35BCD2DC-373E-4701-8FFE-0E337F229F98 @default.
- Q89468198 P921 Q89468198-4B186E3B-B123-4CCD-B806-EEBAB8F32C4B @default.
- Q89468198 P921 Q89468198-6477E366-80C6-42AA-A2FD-12600AC51C2F @default.
- Q89468198 P356 J.JID.2019.11.031 @default.
- Q89468198 P698 32004567 @default.
- Q89468198 P1433 Q3186921 @default.
- Q89468198 P1476 "Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study" @default.
- Q89468198 P2093 "Abdallah Khemis" @default.
- Q89468198 P2093 "Eric Fontas" @default.
- Q89468198 P2093 "Henri Montaudié" @default.
- Q89468198 P2093 "Jean-Philippe Lacour" @default.
- Q89468198 P2093 "Sophie Moulin" @default.
- Q89468198 P31 Q13442814 @default.
- Q89468198 P356 "10.1016/J.JID.2019.11.031" @default.
- Q89468198 P50 Q43280164 @default.
- Q89468198 P577 "2020-01-29T00:00:00Z" @default.
- Q89468198 P698 "32004567" @default.
- Q89468198 P921 Q180152 @default.
- Q89468198 P921 Q269829 @default.